[ORGANIZATION]
KFF
Featured in 5 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
216 clusters · 804 sources · last updated
Latest: GLP-1 drugs face scrutiny over healthcare costs and bone health
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. While research suggests secondary benefits—including a 21% lower risk of fragili
U.S. prescription drug price decline
3 clusters · 16 sources · last updated
Latest: U.S. prescription drug prices see largest annual decline in 60 years
United States prescription drug prices have experienced their largest annual decline since 1963. Data from the Bureau of Labor Statistics indicates a year-over-year drop of between 3.1 percent and 3.9 percent. This downw
US health‑insurance loss, ACA decline, prior‑auth reforms
32 clusters · 83 sources · last updated
Latest: Insurers denied 12% to 18% of prior authorization requests, KFF report
Following the expiration of enhanced federal subsidies on December 31, 2025, Affordable Care Act (ACA) enrollment fell in 49 states. Total enrollment dropped to approximately 19.2 million, down from a 2025 peak of 21.8 m
Also covered in
-
Medicaid coverage declines amid federal budget cuts and new work rules
[POLITICS] · 4 sources ·
-
CMS updates prior authorization transparency guidance
[HEALTH] · 3 sources ·